Business Editors/Health & Medical Writers
NEW YORK--(BUSINESS WIRE)--July 29, 2002
Eon Labs, Inc. (Nasdaq: ELAB) announced today that it received final approval for Etodolac, Extended Release tablets, the generic alternative for the osteoarthritis and rheumatoid arthritis treatment Lodine(R) XL (a).
Eon Lab's approval is for the same strengths as the brand, 400mg, 500mg and 600mg tablets.
Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line includes over 90 generic pharmaceutical products. For more information on specific products manufactured and distributed by the Eon Labs, please call 1-800-526-0225, write Eon Labs Inc., 227-15 North Conduit Avenue, Laurelton, New York, 11413, or visit www.eonlabs.com.
Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.
(a) Lodine XL is a registered trademark of Wyeth-Ayerst Pharmaceuticals and is not affiliated with Eon Labs, Inc.
COPYRIGHT 2002 Business Wire
COPYRIGHT 2002 Gale Group
Contact
Home
A
E-Base